| Eye Care Center | |
|
11724 Retail Dr, Wake Forest, NC 27587-7349 | |
| (919) 562-5559 | |
| (919) 562-5563 |
| Full Name | Eye Care Center |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 11724 Retail Dr, Wake Forest, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518139369 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Provider Name | Jamie J Hanna |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1053592386 PECOS PAC ID: 2567436306 Enrollment ID: I20040825001526 |
News Archive
Ceptaris Therapeutics, Inc., a privately held specialty pharmaceutical company, announced today that the European Medicines Agency (EMA) has granted Orphan Drug Designation to Ceptaris' investigational drug, chlormethine gel, for the treatment of Cutaneous T-Cell Lymphoma.
In Louisiana's Senate race, Medicare is grabbing the spotlight. The powerful issue is also popping up in North Carolina and Iowa. Meanwhile, Michigan's Senate race references to Medicare and the health law are checked for accuracy. And Obamacare is the subject of ads in an increasingly high-profile California House contest.
Among men who had undergone radical prostatectomy, daily consumption of a beverage powder supplement containing soy protein isolate for 2 years did not reduce or delay development of biochemical recurrence of prostate cancer compared to men who received placebo, according to a study in the July 10 issue of JAMA.
Academic medical centers across the U.S. are experiencing increasing pressure to enhance value - deliver higher quality at lower cost - as they continue to face challenges related to outcomes, cost control, market competition, and other dynamics. Initiatives to promote value typically involve reimbursement arrangements between health insurers and providers that align financial, efficiency and quality incentives.
› Verified 6 days ago
| Provider Name | Joel C Swaim |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1053320036 PECOS PAC ID: 9931155066 Enrollment ID: I20050329000383 |
News Archive
Ceptaris Therapeutics, Inc., a privately held specialty pharmaceutical company, announced today that the European Medicines Agency (EMA) has granted Orphan Drug Designation to Ceptaris' investigational drug, chlormethine gel, for the treatment of Cutaneous T-Cell Lymphoma.
In Louisiana's Senate race, Medicare is grabbing the spotlight. The powerful issue is also popping up in North Carolina and Iowa. Meanwhile, Michigan's Senate race references to Medicare and the health law are checked for accuracy. And Obamacare is the subject of ads in an increasingly high-profile California House contest.
Among men who had undergone radical prostatectomy, daily consumption of a beverage powder supplement containing soy protein isolate for 2 years did not reduce or delay development of biochemical recurrence of prostate cancer compared to men who received placebo, according to a study in the July 10 issue of JAMA.
Academic medical centers across the U.S. are experiencing increasing pressure to enhance value - deliver higher quality at lower cost - as they continue to face challenges related to outcomes, cost control, market competition, and other dynamics. Initiatives to promote value typically involve reimbursement arrangements between health insurers and providers that align financial, efficiency and quality incentives.
› Verified 6 days ago
| Provider Name | Thomas R Miller |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1982786216 PECOS PAC ID: 9830370840 Enrollment ID: I20110224000199 |
News Archive
Ceptaris Therapeutics, Inc., a privately held specialty pharmaceutical company, announced today that the European Medicines Agency (EMA) has granted Orphan Drug Designation to Ceptaris' investigational drug, chlormethine gel, for the treatment of Cutaneous T-Cell Lymphoma.
In Louisiana's Senate race, Medicare is grabbing the spotlight. The powerful issue is also popping up in North Carolina and Iowa. Meanwhile, Michigan's Senate race references to Medicare and the health law are checked for accuracy. And Obamacare is the subject of ads in an increasingly high-profile California House contest.
Among men who had undergone radical prostatectomy, daily consumption of a beverage powder supplement containing soy protein isolate for 2 years did not reduce or delay development of biochemical recurrence of prostate cancer compared to men who received placebo, according to a study in the July 10 issue of JAMA.
Academic medical centers across the U.S. are experiencing increasing pressure to enhance value - deliver higher quality at lower cost - as they continue to face challenges related to outcomes, cost control, market competition, and other dynamics. Initiatives to promote value typically involve reimbursement arrangements between health insurers and providers that align financial, efficiency and quality incentives.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eye Care Center 11724 Retail Dr, Wake Forest, NC 27587-7349 Ph: (919) 562-5559 | Eye Care Center 11724 Retail Dr, Wake Forest, NC 27587-7349 Ph: (919) 562-5559 |
News Archive
Ceptaris Therapeutics, Inc., a privately held specialty pharmaceutical company, announced today that the European Medicines Agency (EMA) has granted Orphan Drug Designation to Ceptaris' investigational drug, chlormethine gel, for the treatment of Cutaneous T-Cell Lymphoma.
In Louisiana's Senate race, Medicare is grabbing the spotlight. The powerful issue is also popping up in North Carolina and Iowa. Meanwhile, Michigan's Senate race references to Medicare and the health law are checked for accuracy. And Obamacare is the subject of ads in an increasingly high-profile California House contest.
Among men who had undergone radical prostatectomy, daily consumption of a beverage powder supplement containing soy protein isolate for 2 years did not reduce or delay development of biochemical recurrence of prostate cancer compared to men who received placebo, according to a study in the July 10 issue of JAMA.
Academic medical centers across the U.S. are experiencing increasing pressure to enhance value - deliver higher quality at lower cost - as they continue to face challenges related to outcomes, cost control, market competition, and other dynamics. Initiatives to promote value typically involve reimbursement arrangements between health insurers and providers that align financial, efficiency and quality incentives.
› Verified 6 days ago
Heritage Eye Care, Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3211 Rogers Rd, Ste 100, Wake Forest, NC 27587 Phone: 919-453-1220 | |
Kris Janik Roy, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2114 S Main St, Wake Forest, NC 27587 Phone: 919-556-1530 | |
Dr. Lee Doyle Mcpherson, O.D., M.P.H. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3150 Rogers Rd, Suite 110, Wake Forest, NC 27587 Phone: 919-263-6163 Fax: 919-263-9408 | |
Jamie Jones Hanna, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 11724 Retail Dr, Wake Forest, NC 27587 Phone: 919-562-5559 Fax: 919-562-5563 | |
Heritage Eye Care, Od Optometrist Medicare: Medicare Enrolled Practice Location: 3211 Rogers Rd Ste 100, Wake Forest, NC 27587 Phone: 919-453-1220 Fax: 919-453-1221 | |
Mcpherson Family Eye Care Od, Pa Optometrist Medicare: Medicare Enrolled Practice Location: 3150 Rogers Rd, Suite 110, Wake Forest, NC 27587 Phone: 919-263-9163 Fax: 919-263-9408 | |
Dr. Chad Christopher Raymond Morgan, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 110 Capcom Ave, Wake Forest, NC 27587 Phone: 919-556-1909 Fax: 919-556-6765 |